Literature DB >> 25739758

A new live-cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies.

Marieke I G Raaijmakers1, Daniel S Widmer, Melanie Maudrich, Tabea Koch, Alice Langer, Anna Flace, Claudia Schnyder, Reinhard Dummer, Mitchell P Levesque.   

Abstract

Fibroblast contamination can make establishing primary melanoma cell cultures from native biopsies a major challenge, due to fibroblasts overgrowing the melanoma cells. Standard protocols therefore enrich for highly proliferative melanoma cells that grow well in vitro but may not represent the full range of in vivo tumor heterogeneity. Here we apply conditional methods that more effectively retrieve melanoma cells by differential trypsinization or by inducing fibroblast senescence through contact inhibition, serum starvation or deprivation of adhesion. Simple mixing experiments of melanoma and fibroblast cells demonstrated the efficacy of the new protocols in retrieving slow-growing melanoma cells. Applying our protocols to 20 cultures that had failed to grow by conventional methods, we could retrieve 12 (60%) validated melanoma cell cultures. Further application of the protocols in the live-cell biobank of 124 early passage cultures significantly improved recovery rates from 13% using standard protocols to 70% overall for the new workflow.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  biobank; cell culture; fibroblast overgrowth; melanoma

Mesh:

Year:  2015        PMID: 25739758     DOI: 10.1111/exd.12683

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  14 in total

1.  Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.

Authors:  Joanna Poźniak; Jérémie Nsengimana; Jonathan P Laye; Sally J O'Shea; Joey Mark S Diaz; Alastair P Droop; Anastasia Filia; Mark Harland; John R Davies; Tracey Mell; Juliette A Randerson-Moor; Sathya Muralidhar; Sabrina A Hogan; Sandra Nicole Freiberger; Mitchell P Levesque; Graham P Cook; D Timothy Bishop; Julia Newton-Bishop
Journal:  Cancer Res       Date:  2019-02-17       Impact factor: 12.701

2.  SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma Growth.

Authors:  Bertrand Fabre; Yongmei Feng; Ikrame Lazar; Ali Khateb; Patrick Turko; Julia M Martinez Gomez; Dennie T Frederick; Mitchell P Levesque; Lea Feld; Gao Zhang; Tongwu Zhang; Brian James; Jeny Shklover; Emily Avitan-Hersh; Ido Livneh; Marzia Scortegagna; Kevin Brown; Ola Larsson; Ivan Topisirovic; Haguy Wolfenson; Meenhard Herlyn; Keith Flaherty; Reinhard Dummer; Ze'ev A Ronai
Journal:  Mol Cancer Res       Date:  2020-06-22       Impact factor: 5.852

3.  Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Authors:  Verena Paulitschke; Ossia Eichhoff; Christopher Gerner; Philipp Paulitschke; Andrea Bileck; Thomas Mohr; Phil F Cheng; Alexander Leitner; Emmanuella Guenova; Ieva Saulite; Sandra N Freiberger; Anja Irmisch; Bernhard Knapp; Nina Zila; Theodora-Pagona Chatziisaak; Jürgen Stephan; Joanna Mangana; Rainer Kunstfeld; Hubert Pehamberger; Ruedi Aebersold; Reinhard Dummer; Mitchell P Levesque
Journal:  EMBO J       Date:  2019-06-26       Impact factor: 11.598

4.  A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors.

Authors:  Mitchell P Levesque; Werner J Kovacs; Andrea Aloia; Daniela Müllhaupt; Christophe D Chabbert; Tanja Eberhart; Stefanie Flückiger-Mangual; Ana Vukolic; Ossia Eichhoff; Anja Irmisch; Leila T Alexander; Ernesto Scibona; Dennie T Frederick; Benchun Miao; Tian Tian; Chaoran Cheng; Lawrence N Kwong; Zhi Wei; Ryan J Sullivan; Genevieve M Boland; Meenhard Herlyn; Keith T Flaherty; Nicola Zamboni; Reinhard Dummer; Gao Zhang; Wilhelm Krek
Journal:  Clin Cancer Res       Date:  2019-08-02       Impact factor: 12.531

5.  VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruption.

Authors:  Ana B García-Martín; Pascale Zwicky; Thomas Gruber; Christoph Matti; Federica Moalli; Jens V Stein; David Francisco; Gaby Enzmann; Mitchell P Levesque; Ekkehard Hewer; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-15       Impact factor: 6.200

6.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

7.  Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.

Authors:  Nathaniel R Campbell; Anjali Rao; Miranda V Hunter; Magdalena K Sznurkowska; Luzia Briker; Maomao Zhang; Maayan Baron; Silja Heilmann; Maxime Deforet; Colin Kenny; Lorenza P Ferretti; Ting-Hsiang Huang; Sarah Perlee; Manik Garg; Jérémie Nsengimana; Massimo Saini; Emily Montal; Mohita Tagore; Julia Newton-Bishop; Mark R Middleton; Pippa Corrie; David J Adams; Roy Rabbie; Nicola Aceto; Mitchell P Levesque; Robert A Cornell; Itai Yanai; Joao B Xavier; Richard M White
Journal:  Dev Cell       Date:  2021-09-15       Impact factor: 12.270

8.  Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.

Authors:  Phil F Cheng; Olga Shakhova; Daniel S Widmer; Ossia M Eichhoff; Daniel Zingg; Sandra C Frommel; Benedetta Belloni; Marieke Ig Raaijmakers; Simone M Goldinger; Raffaella Santoro; Silvio Hemmi; Lukas Sommer; Reinhard Dummer; Mitchell P Levesque
Journal:  Genome Biol       Date:  2015-02-22       Impact factor: 13.583

9.  Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.

Authors:  Marieke I G Raaijmakers; Daniel S Widmer; Apurva Narechania; Ossia Eichhoff; Sandra N Freiberger; Judith Wenzina; Phil F Cheng; Daniela Mihic-Probst; Rob Desalle; Reinhard Dummer; Mitchell P Levesque
Journal:  Oncotarget       Date:  2016-11-22

10.  low neurotrophin receptor CD271 regulates phenotype switching in melanoma.

Authors:  Gaetana Restivo; Johanna Diener; Phil F Cheng; Gregor Kiowski; Mario Bonalli; Thomas Biedermann; Ernst Reichmann; Mitchell P Levesque; Reinhard Dummer; Lukas Sommer
Journal:  Nat Commun       Date:  2017-12-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.